Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases Podcast Por arte de portada

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

Escúchala gratis

Ver detalles del espectáculo
In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies. Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future. Related content: https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272

https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597
Todavía no hay opiniones